Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker BLTE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 2,700 | $198.09 | $534.8K Sale | Form 4 ↗ |
| Sep 8, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 8,752 | $197.36 | $1.7M Sale | Form 4 ↗ |
| Sep 8, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 6,058 | $196.54 | $1.2M Sale | Form 4 ↗ |
| Sep 8, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 6,090 | $195.62 | $1.2M Sale | Form 4 ↗ |
| Sep 8, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 2,400 | $194.33 | $466.4K Sale | Form 4 ↗ |
| Sep 8, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 2,562 | $198.05 | $507.4K Sale | Form 4 ↗ |
| Sep 8, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 4,605 | $197.23 | $908.2K Sale | Form 4 ↗ |
| Sep 8, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 4,475 | $196.47 | $879.2K Sale | Form 4 ↗ |
| Sep 8, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 4,120 | $195.60 | $805.9K Sale | Form 4 ↗ |
| Sep 8, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 2,200 | $194.28 | $427.4K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 8,111 | $193.13 | $1.6M Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 4,209 | $192.54 | $810.4K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 11,080 | $191.15 | $2.1M Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 600 | $190.39 | $114.2K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 8,955 | $189.34 | $1.7M Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 3,045 | $188.26 | $573.3K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 6,200 | $187.25 | $1.2M Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 7,800 | $186.32 | $1.5M Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 4,593 | $185.34 | $851.3K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 6,252 | $184.52 | $1.2M Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 4,955 | $183.30 | $908.3K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 3,413 | $182.50 | $622.9K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 2,587 | $181.24 | $468.9K Sale | Form 4 ↗ |
| Sep 4, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 2,635 | $180.29 | $475.1K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 4,602 | $193.12 | $888.7K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 3,398 | $192.40 | $653.8K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 6,200 | $191.09 | $1.2M Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 1,800 | $190.63 | $343.1K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 6,200 | $189.22 | $1.2M Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 1,900 | $188.59 | $358.3K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 3,900 | $187.16 | $729.9K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 4,600 | $186.35 | $857.2K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 3,872 | $185.28 | $717.4K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 3,569 | $184.57 | $658.7K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 3,759 | $183.27 | $688.9K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 2,000 | $182.49 | $365.0K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 2,000 | $181.05 | $362.1K Sale | Form 4 ↗ |
| Sep 4, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 1,633 | $180.16 | $294.2K Sale | Form 4 ↗ |
| Aug 12, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 223 | $180.57 | $40.3K Sale | Form 4 ↗ |
| Aug 12, 2026 | Hao-Yuan Chuang Chief Financial Officer, Director | BLTE Belite Bio, Inc | Sale | 144 | $180.00 | $25.9K Sale | Form 4 ↗ |
| Aug 12, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 223 | $180.57 | $40.3K Sale | Form 4 ↗ |
| Aug 12, 2026 | Yu-Hsin Lin Chief Executive Officer, Director | BLTE Belite Bio, Inc | Sale | 142 | $180.00 | $25.6K Sale | Form 4 ↗ |
| Jun 18, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 96 | $147.11 | $14.1K Sale | Form 4 ↗ |
| Jun 18, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 1,199 | $146.24 | $175.3K Sale | Form 4 ↗ |
| Jun 18, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 4,861 | $145.43 | $706.9K Sale | Form 4 ↗ |
| Jun 18, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 3,748 | $144.66 | $542.2K Sale | Form 4 ↗ |
| Jun 18, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 96 | $143.90 | $13.8K Sale | Form 4 ↗ |
| Jun 16, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 1,035 | $145.02 | $150.1K Sale | Form 4 ↗ |
| Jun 16, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 1,897 | $143.55 | $272.3K Sale | Form 4 ↗ |
| Jun 16, 2026 | Hendrik Peter Scholl Chief Medical Officer | BLTE Belite Bio, Inc | Sale | 450 | $142.20 | $64.0K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:44 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances